Ocuphire Pharma Profit Margin 2010-2024 | IRD
Current and historical gross margin, operating margin and net profit margin for Ocuphire Pharma (IRD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ocuphire Pharma net profit margin as of June 30, 2024 is 0%.
| Ocuphire Pharma Annual Profit Margins |
| Ocuphire Pharma Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.000B |
$0.000B |
|
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|
